South Africa, Eswatini and Zambia on Monday began administering a new HIV-prevention injection, marking the first public ...

In India, significant strides have been made in the fight against AIDS. However, progress has not been uniform across the ...

In a statement issued ahead of World AIDS Day, activists highlighted the scale of need in Africa: at least 10 million people ...

More than 5,600 people have died of Acquired Immune Deficiency Syndrome in Mizoram since the deadly virus was first detected in October 1990.

According to UNAIDS 2024, eastern and southern Africa account for 52% of the 40.8 million people living with HIV worldwide.

In 2024, over half of patients found to have HIV in Europe received a late diagnosis, which is often associated with poor ...

Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read more on GILD stock here.

Bristol Myers Squibb BMY and Gilead Sciences, Inc. GILD are leading biotechnology companies with broad, diverse portfolios ...

(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Robin Lin Miller, Michigan State University (THE CONVERSATION) Protecting public ...

Africa is home to 15% of the world’s population but carries more than a quarter of the global disease burden, yet contributes ...

In the 1980s, the human immunodeficiency virus (HIV) was a global scourge, decimating communities. When it was identified in the blood products supply chain, people were terrified.

According to DataM Intelligence, the HIV Therapeutics Market Size grew to USD 37.61 billion in 2024 and is projected to reach USD 57.56 billion by 2033, advancing at a CAGR of 4.8% during the forecast ...